Target intelligence / Profile preview

Coiled-coil glutamate-rich protein 1 (CCER1)

Target
CCER1
Molecular classification
Other (intrinsically disordered, testis-specific nuclear protein with regulatory and scaffolding properties; not a receptor, enzyme, or typical signaling molecule)
01

Overview

Coiled-coil glutamate-rich protein 1 (CCER1) is an intrinsically disordered, testis-specific nuclear protein found in vertebrates, highly enriched in round and elongating spermatids during spermiogenesis. CCER1 regulates the histone-to-protamine transition, promoting chromatin compaction required for sperm maturation; it exerts these effects by mediating histone epigenetic modifications, self-assembling into liquid–liquid phase-separated nuclear condensates, and acting as a scaffold for chromatin and histone-modifying enzymes. Loss-of-function mutations or deletions of CCER1 in humans and mice result in defective sperm nuclear condensation and infertility, and rare pathogenic human CCER1 variants are linked to nonobstructive azoospermia. CCER1 is not a classical therapeutic target, with no established roles as an enzyme, receptor, transporter, or signaling molecule, but instead serves as a crucial germline determinant of sperm development and a marker for certain steps of spermatid differentiation.

Other names
Coiled-coil domain-containing glutamate-rich protein 1CCER1C12orf12MGC26598
02

Mechanism of action

Not applicable (no drugs targeting CCER1 characterized)

03

Biological functions

Chromatin remodeling and compactionRegulation of histone epigenetic modificationsFacilitation of histone-to-protamine (HTP) transition in spermatid nucleiEssential for normal spermiogenesis and male fertility
04

Disease associations

Male infertility (including nonobstructive azoospermia, linked to loss-of-function mutations)
05

Safety considerations

Not applicable (not a drug target; loss-of-function is causally linked to male infertility, but there are no reports of on-target/off-target toxicities associated with pharmacological modulation)
06

Interacting drugs

None known (no reports of drug interactions or therapeutic targeting in literature as of 2025)
07

Biomarkers

Marker for differentiating spermatids and specific stages of spermatogenesis

Beyond the preview

Go deeper on Coiled-coil glutamate-rich protein 1 (CCER1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil glutamate-rich protein 1 (CCER1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call